Alternating electric field waveform for electro-sensitive reduction
By applying the electric field at high frequency and low intensity during the duty cycle of the alternating electric field, and gradually increasing the intensity and reducing the frequency, the electrical sensitivity problem in alternating electric field treatment is solved, and the tolerance and effectiveness of the treatment is improved.
Patent Information
- Application Number
- CN202380031384.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-03-30
- Filing Date
- 2023-03-31
- Publication Date
- 2024-11-15
AI Technical Summary
When treating tumors with alternating electric fields, subjects may experience electrosensitive effects at higher intensity and low frequency, affecting the persistence of treatment.
The occurrence of electrical sensitivity is avoided by applying the electric field at a higher frequency during the start of the duty cycle of the alternating electric field and switching to the optimal treatment frequency when the electric field reaches its peak intensity. The specific method includes applying an alternating electric field at lower intensity and high frequency during the darkening period and gradually increasing the intensity and decreasing the frequency until the target intensity and frequency are reached.
Effectively reduce or eliminate electrical sensitivity, improve subjects' tolerance to alternating electric field treatment, and improve the effectiveness of treatment.
Smart Images

Figure CN118973660A_ABST
Abstract
Description
[0001] Cross-references
[0002] This application claims priority to U.S. Patent Application No. 18 / 128,937 filed on March 30, 2023, U.S. Provisional Application No. 63 / 326,098 filed on March 31, 2022, and U.S. Provisional Application No. 63 / 410,481 filed on September 27, 2022, the entire contents of which are incorporated herein by reference. Background Art
[0003] Tumor Treatment Fields (TTFields) are low-intensity alternating electric fields in the mid-frequency range that can be used to treat tumors, as described in U.S. Patent No. 7,565,205. Tumor Treatment Fields are non-invasively induced into the region of interest by transducers that are placed directly on the patient's body and apply an AC voltage between the transducers. An AC voltage is applied between a first pair of transducers for a first time interval to generate an electric field having field lines extending generally in a front-to-back direction. Then, an AC voltage is applied between a second pair of transducers for a second time interval at the same frequency to generate an electric field having field lines extending generally in a side-to-side direction. The system then repeats this two-step sequence throughout the treatment. BRIEF DESCRIPTION OF THE DRAWINGS
[0004] Figure 1A Exemplary methods of treating a target area of a subject's body are depicted.
[0005] Figure 1B Exemplary methods of treating a target area of a subject's body are depicted.
[0006] Figure 2 An exemplary system with four transducers is depicted.
[0007] Figure 3 An exemplary device for controlling an alternating electric field is depicted.
[0008] Figures 4 to 6 Exemplary waveforms of alternating electric fields are depicted.
[0009] Figure 7 Another exemplary method of treating a target area of a subject's body is depicted.
[0010] Figure 8 An exemplary method of delivering an alternating electric field to a subject's body is depicted.
[0011] Fig. 9 An exemplary method of delivering an alternating electric field to a subject's body when temperature is elevated is depicted.
[0012] Fig.10 An exemplary cytotoxicity assay showing the effect of field strength is depicted.
[0013] FIG. 11A to FIG. 11C Depicted is the experimental stimulation of the rat sciatic nerve fascicle with an alternating electric field. DETAILED DESCRIPTION
[0014] The present application describes exemplary systems and methods for delivering alternating electric fields to a subject's body to treat the subject's body. Specifically, the present invention relates to systems and methods for applying alternating electric fields according to waveforms that reduce electrosusceptibility in a subject.
[0015] When treating a subject with an alternating electric field, higher intensities (e.g., amplitudes) may be strongly associated with higher therapeutic efficacy. However, at higher intensities (e.g., amplitudes) of the alternating electric field and / or lower frequencies (e.g., around 100 kHz) of the alternating electric field, some subjects experience electrosensitivity effects, particularly at the start of the alternating electric field.
[0016] The electrosensitivity may arise from the interaction between the alternating electric field and nerve cells located near or adjacent to the transducer array that induces the alternating electric field. For example, an AC current of a given frequency may be coupled into a subject through a pair of identical electrodes that are located on the subject's skin for applying an alternating electric field. When the current density (e.g., the current passing through any given electrode divided by the area of the electrode) is below a threshold value (which may vary from person to person), electrosensitivity may not occur. However, when the current density rises above the threshold value, electrosensitivity may begin to occur, and when the current density increases further, electrosensitivity becomes more pronounced. This electrosensitivity may be, for example, a vibration sensation, paresthesia, and / or a twitch or contraction sensation in a muscle fiber. These sensations may prevent some subjects from continuing treatment with an alternating electric field.
[0017] The inventors recognized these problems and discovered methods and systems for reducing or eliminating electrosensitivity when treating a subject with an alternating electric field. In particular, the inventors recognized that electrosensitivity occurs in response to the current density present during the beginning of the duty cycle of the alternating electric field. The present invention is directed to systems and methods for completely avoiding electrosensitivity at the beginning of the duty cycle by applying the alternating electric field at a higher frequency during the dimming period. The alternating electric field is applied to the subject's body using a voltage generated from an AC voltage waveform. At a given duty cycle, the AC voltage waveform has a higher frequency during the dimming period and then switches to an optimal frequency for treating the subject's body at or near peak intensity of the electric field. This mixed frequency AC voltage waveform helps avoid electrosensitivity that may occur when the optimal frequency for treating the subject's body is used during the entire duty cycle.
[0018] The inventors have discovered systems and methods for minimizing electrosensitivity at the beginning of a duty cycle by applying an alternating electric field at a lower intensity and a higher frequency during a dimming period. The alternating electric field can be applied to a subject's body using a voltage generated from an AC voltage waveform. During the dimming period of the duty cycle, the AC voltage waveform initially has an intensity lower than a target intensity and a frequency higher than a target frequency. As the dimming period progresses, the intensity is increased to the target intensity and the frequency is decreased to the target frequency. This AC voltage waveform can help avoid electrosensitivity that may occur when a target intensity and a target frequency are used to treat the subject's body during the entire duty cycle.
[0019] Figure 1A An exemplary method 100 for treating a target area of a subject's body with an alternating electric field is depicted. In step S102, method 100 may include determining a target frequency and a target intensity for applying the alternating electric field. In one example, the target area may include at least one of a cancer, a tumor, an endothelial or epithelial tight junction (e.g., such as a blood-brain barrier (BBB) or intestinal wall tight junction), or any tissue or cell of the subject. In one example, the target area may be determined by treating a viral infection, a bacterial infection, a neurodegenerative disease, and / or an autoimmune disease. In some embodiments, when an alternating electric field having a target intensity and a target frequency is applied, the subject may experience electrosensitivity.
[0020] The term "target frequency" as used herein may refer to a clinically recognized frequency that can provide known efficacy for the desired treatment of a subject using an alternating electric field applied to the subject at the target frequency. For example, the target frequency may be a clinically recognized frequency that provides a proven efficacy against tumor cell proliferation or opening of endothelial or epithelial tight junctions. For example, the target frequency can be determined from an in vitro assay. The term "target frequency" may also refer to a frequency that is more effective than a first frequency for the intended treatment. Typically, the target frequency is lower than the first frequency. The target frequency may be within a target frequency range corresponding to a specific target cell, tissue, and / or treatment.
[0021] In a non-limiting embodiment, the target frequency can be about 50kHz to about 10MHz, about 50kHz to about 1MHz, about 50kHz to about 500kHz, or about 100kHz to about 400kHz. For example, if the target area is glioblastoma (GBM), the target frequency for treating GBM can be about 100kHz to about 300kHz (e.g., 50kHz-350kHz, or 150kHz-250kHz, or 200kHz). For example, if the treatment goal is to reduce tumor cell proliferation, the target frequency can be about 100kHz to about 400kHz (e.g., 150kHz-200kHz, or 140kHz-220kHz). As another example, if the target area is epithelial or endothelial tight junctions, the target frequency can be about 50kHz to about 190kHz (e.g., 75kHz-190kHz, or 100kHz, or 150kHz) for opening epithelial or endothelial tight junctions. As another example, if the treatment goal is to change the cancer cell membrane permeability (e.g., increase the cancer cell membrane permeability), the target frequency can be about 100kHz to about 500kHz (e.g., 50kHz-550kHz, or 150kHz-350kHz, or 250kHz-400kHz). For example, if the treatment goal is to treat non-small cell lung cancer (NSCLC), the target frequency can be about 100kHz to about 200kHz (e.g., 150kHz). For example, if the target area / tissue is pancreatic tissue / cancer, the target frequency can be about 100kHz to about 200kHz (e.g., 150kHz). For example, if the target area / tissue is ovarian tissue / cancer, the target frequency can be about 150kHz to about 250kHz (e.g., 200kHz). For example, if the target area / tissue is gastric tissue / cancer, the target frequency can be about 100kHz to about 200kHz (e.g., 150kHz). Although the present invention describes and illustrates a specific frequency range, the present invention contemplates any target frequency range configured to produce a proven efficacy for treating a subject.
[0022] In some embodiments, the term "target intensity" can refer to a clinically recognized intensity that can provide a known efficacy for the desired treatment of a subject using an alternating electric field applied to a subject at the target intensity. For example, the target intensity can be a clinically recognized intensity that provides a proven efficacy against tumor cell proliferation or opening epithelial or endothelial tight junctions. For example, the target intensity can be determined from an in vitro assay.
[0023] In some embodiments, the term "target intensity" may refer to an intensity that is more effective for the intended treatment than a first intensity applied to the subject. Typically, the target intensity is higher than the first intensity. In certain embodiments, the target intensity may be within a range of target intensities corresponding to specific target cells, tissues, and / or treatments.
[0024] In some embodiments, the term "target intensity" may refer to an intensity based on a temperature associated with an alternating electric field applied to a subject's body. For example, the target intensity may be based on the temperature of the subject's body measured at a location on the subject's body that receives the alternating electric field. For example, the target intensity may be based on the temperature of an electrode that provides the alternating electric field to the subject's body. For example, the target intensity may be the maximum intensity that can be achieved if the subject's body and / or the electrode that applies the alternating electric field exceeds a temperature threshold between a range (e.g., between about 37° C. and about 43° C.).
[0025] In some embodiments, the term "target intensity" may refer to a combination of two or more of the above exemplary target intensities, either collectively and / or in alternative forms.
[0026] In a non-limiting embodiment, the target intensity can be about 0.5V / cm to about 10V / cm, or about 0.1V / cm to about 20V / cm. For example, if the target area is GBM, the target intensity for treating GBM can be about 1V / cm to about 5V / cm (e.g., 1V / cm-3V / cm). For example, if the treatment goal is to reduce tumor cell proliferation, the target intensity can be about 1V / cm to about 5V / cm (e.g., 1V / cm-3V / cm). For example, if the target area is the BBB, the target intensity for opening the BBB can be about 1V / cm to about 5V / cm (e.g., 1V / cm-3V / cm). For example, if the treatment goal is to change cell membrane permeability (e.g., increase cell membrane permeability), the target intensity can be about 1V / cm to about 5V / cm (e.g., 1V / cm-3V / cm).
[0027] Although the present invention describes and illustrates a specific frequency range and intensity range, the present invention contemplates any target frequency range and any target intensity range with known efficacy for treating a subject. In a non-limiting embodiment, the target frequency and / or target intensity may vary according to the target area.
[0028] At step S104, method 100 may include selecting a first frequency to reduce electrosensitivity in the body of the subject. When the intensity is ramped up to the target intensity, the alternating electric field starting at the first frequency can reduce the electrosensitivity of the subject compared to the alternating electric field applied at the target frequency. In one example, the first frequency can be selected by gradually reducing the frequency level of the alternating electric field from the initial frequency until the subject experiences electrosensitivity, as indicated by the subject's response. In one example, the first frequency can be selected by gradually reducing the frequency level of the alternating electric field from the initial frequency until the subject experiences electrosensitivity, as indicated by an objective measurement such as detecting neural stimulation.
[0029] The first frequency is greater than the target frequency. For example, the first frequency can be at least about 10% higher than the target frequency (e.g., at least about 20%, 30%, 50%, 75%, 100%, 150%, 200% or 300%). As another example, the first frequency can be at least about 10kHz higher than the target frequency (e.g., at least about 20kHz, 30kHz, 50kHz, 75kHz, 100kHz, 150kHz, 200kHz or 300kHz). In one example, the first frequency can be between about 100kHz and about 400kHz, between about 200kHz and about 600kHz, between about 300kHz and about 800kHz, or between about 50kHz and about 350kHz. In one example, the first frequency can be up to 900kHz, 1MHz, 10MHz or higher. The first frequency can depend on the current applied to the transducer pair. Typically, the subject feels a greater degree of electrical sensitivity at higher intensities. Thus, in some embodiments, a higher first frequency may be used when a higher intensity (e.g., a higher current) is applied to compensate for a greater degree of electrosensitivity at the higher intensity. For example, in an embodiment where 2 amps of current are applied, the first frequency may be between about 300 kHz and 400 kHz. As another example, in an embodiment where 4 amps of current are applied, the first frequency may be between about 500 kHz and 600 kHz. In certain embodiments, the first frequency may be predetermined based on certain criteria, such as the type of treatment, the part of the subject's body to which the transducer will be applied, and / or other information about the subject.
[0030] At step S106, method 100 includes applying an alternating electric field to a target area of the subject's body at a first frequency while increasing the intensity of the alternating electric field from zero to a target intensity. This represents the beginning of a duty cycle of the alternating electric field. The duty cycle of the alternating electric field may begin by applying the alternating electric field at a first frequency while ramping up (or "dimming") the intensity of the alternating electric field.
[0031] In step S108, method 100 includes changing the frequency of the alternating electric field from a first frequency to a target frequency while maintaining the alternating electric field at a target intensity. In particular, the frequency of the alternating electric field is reduced from a first frequency to a target frequency that is optimal for treating the body of the subject. In one example, the frequency change can be immediate, or can take less than about 200ms, less than about 100ms, less than about 50ms, less than about 25ms, less than about 10ms, less than about 5ms, less than about 1ms, or less than about 0.1ms to occur. In another example, the frequency change can be gradual (e.g., taking at least about 0.1ms, at least about 1ms, at least about 5ms, at least about 10ms, at least about 25ms, at least about 50ms, at least about 100ms, or at least about 200ms to occur and / or in a stepwise manner). The change in frequency can occur immediately when the alternating electric field reaches the target intensity, or occurs shortly after the alternating electric field reaches the target intensity.
[0032] The alternating electric field may continue at the target frequency until a first time period has elapsed at step S110. The first time period may be less than about 3 seconds (eg, less than about 2 seconds, or less than about 1 second).
[0033] After the first time period (S110), method 100 may include, at step S112, stopping applying the alternating electric field to complete a first duty cycle of the alternating electric field. The alternating electric field may be configured to reduce electrosensitivity of the subject compared to when the alternating electric field is applied at the target frequency throughout its duty cycle.
[0034] At step S114, method 100 may include determining whether a second time period has elapsed. The second time period may be from about 12 hours to about 4 weeks (e.g., between about 48 hours and 3 weeks, or between about 1 week and 2 weeks). If the second time period has not elapsed, method 100 may repeat steps S106 to S114. That is, method 100 may include applying one or more subsequent duty cycles of the alternating electric field of steps S106 to S112. In some embodiments, method 100 may include alternating the duty cycle of applying the alternating electric field via the first pair of transducer arrays and via the second pair of transducer arrays.
[0035] Once the second time period (S114) has passed, method 100 may include, at step S116, switching from applying the alternating electric field to the target area of the subject's body to applying a second alternating electric field to the target area of the subject's body at a second frequency that is lower than the first frequency and is close to or at the target frequency in each duty cycle. After the second time period (S114), the subject's body may be desensitized to the current density at the electrode / skin interface such that the subject will no longer experience electrosensitization during the dimmed period. In this way, the second alternating electric field having a lower (or target) frequency throughout the duty cycle may be well tolerated by the subject and used to provide higher therapeutic efficacy.
[0036] In some embodiments, the alternating electric field can be applied to the target area cyclically. Cyclic treatment includes applying the alternating electric field for a period of time, then resting for a period of time, and repeating this sequential administration. Cyclic treatment can reduce or avoid electrosensitivity and / or can improve the efficacy of treatment. In non-limiting embodiments, the number of cycles can be from about 1 to about 50, or from about 1 to about 24. In one example, the rest time can be from about ten seconds to about one week. In certain embodiments, treatment stops when the subject experiences electrosensitivity and / or cannot tolerate the side effects associated with the alternating electric field.
[0037] When the second alternating electric field is applied, the subject's body may not experience electrosensitivity. In one example, the second alternating electric field may have a second frequency that is closer to or at the target frequency than the first frequency. In one example, the second alternating electric field may have a second intensity that is closer to or at the target intensity than the first intensity. In one example, the second alternating electric field may have a second frequency and a second intensity, which are the target frequency and the target intensity. In a non-limiting embodiment, the first alternating electric field can be continuously switched to the second alternating electric field without shutting down the system / transducer for a waiting time. In one example, the alternating electric field can be applied with or without pausing, while changing the parameters of the alternating electric field between the first group and the second group. In one example, the alternating electric field with the first frequency and the first intensity can be stopped, and the second alternating electric field can be applied to the target area of the subject's body. "Stop" can refer to suspending the alternating electric field so that the alternating electric field is not applied, or changing the parameters of the alternating electric field so that a different alternating electric field can actually be applied then.
[0038] It should be noted that the target frequency, target intensity, first frequency, first time period, and second time period can be specifically tailored to the individual subject being treated based on the target area and / or the presence or amount of electrosensitivity felt by the subject.
[0039] In one example, the alternating electric field can be applied to the target area in a single dose or divided doses. For example, the alternating electric field can be applied to the target area once a day, twice a day, once a week, twice a week, three times a week, four times a week, five times a week, six times a week, once every two weeks, once a month, twice a month, once every other month, or once every three months.
[0040] During the treatment dose, the patient may interrupt the treatment in the treatment and it is still considered as a dose. For example, the patient can receive alternating electric field treatment and rest for about 80% of the time. In one example, in order to open the BBB, the patient can wear or equip the disclosed system / device for about three days (e.g., about 72 hours) to open the BBB, but can be interrupted during the treatment time. For tumors, the device can use an extended time period (indefinitely), again with a pause for showering, swimming, changing arrays, etc., with the goal of 80% of the treatment time performed by the array. For example, if "once a month" is at least 72 hours, once a month can be used for BBB application, but for tumors, it may be necessary to use the device for a longer time.
[0041] In one example, the alternating electric field can be applied to the target area at predetermined time intervals. For example, the time intervals can be based on how long a typical subject may experience electrosensitivity at the target frequency and / or target intensity. For example, the time intervals can be based on how long a subject experiences electrosensitivity at the target frequency and / or target intensity. Such time intervals can be based on the subject's subjectivity.
[0042] In one example, the predetermined time interval (e.g., duration of alternating electric field treatment) can be between about one second and about 1 month. For example, the interval can be about 1 hour to about 12 hours, about 12 hours to about 24 hours, about 1 day to about 3 days, about 3 days to about 7 days, about 1 week to about 2 weeks, or about 1 week to about 3 weeks.
[0043] Figure 1B An exemplary method 150 for treating a target area of a subject's body with an alternating electric field is described. The target area may be a region similar to that described above with respect to Figure 1A The method 150 may include step 102, such as Figure 1A shown.
[0044] At step S124, method 150 may include selecting a first frequency and a first intensity to reduce electrosensitivity in the subject's body. During dimming, the first frequency and the first intensity of the alternating electric field are adjusted to a target frequency and a target intensity, which can reduce electrosensitivity in the subject compared to initially applying the alternating electric field having the target frequency and / or the target intensity. As described above, during Figure 1A In step S104, the first frequency is greater than the target frequency.
[0045] The first intensity is less than the target intensity. For example, the first intensity can be at least about 10% lower than the target intensity (e.g., at least about 20% lower, 30% lower, 50% lower, 75% lower, 100% lower, 150% lower, 200% lower, or 300% lower). For example, the first intensity can be at least 0.1 V / cm lower than the target intensity (e.g., at least about 0.2 V / cm, 0.3 V / cm, 0.4 V / cm, 0.5 V / cm, 0.6 V / cm, 0.7 V / cm, 0.8 V / cm, 0.9 V / cm, 1 V / cm, 1.5 V / cm, 2 V / cm, 2.5 V / cm, 3.0 V / cm, 3.5 V / cm, or 4.5 V / cm lower). In one example, the first intensity can be between about 0.1 V / cm and about 4.5 V / cm, between about 0.5 V / cm and about 3.0 V / cm, between about 0.1 V / cm and about 2.5 V / cm. In one example, the first intensity can be 0 V / cm, slightly above 0 V / cm, or about 0 V / cm.
[0046] At step S126, method 150 includes applying an alternating electric field to a target area of the subject's body while increasing the intensity of the alternating electric field from a first intensity to a target intensity and decreasing the frequency of the electric field from a first frequency to a target frequency. This represents the beginning of a duty cycle of the alternating electric field. The duty cycle of the alternating electric field may begin by applying an alternating electric field of a first intensity and a first frequency, while ramping up (or "dimming") the intensity of the alternating electric field and while decreasing the frequency of the alternating electric field.
[0047] In one example, the frequency change can be immediate, or can take less than about 200 ms, less than about 100 ms, less than about 50 ms, less than about 25 ms, less than about 10 ms, less than about 5 ms, less than about 1 ms, or less than about 0.1 ms to occur. In another example, the frequency change can be gradual (e.g., taking at least about 0.1 ms, at least about 1 ms, at least about 5 ms, at least about 10 ms, at least about 25 ms, at least about 50 ms, at least about 100 ms, or at least about 200 ms to occur and / or occurs in a stepwise manner).
[0048] A change in frequency can correspond to an equivalent change in intensity. Alternatively, the rate of increase in intensity and the rate of decrease in frequency can be different. The rate of increase in intensity and the rate of decrease in frequency need not be started and stopped at the same time. In some embodiments, an overlap of increased intensity and decreased frequency occurs at the beginning of treatment (e.g., overlap may occur at least within, for example, the first 0.1 seconds of treatment).
[0049] In one example, the intensity can be immediate, or can take less than about 200 ms, less than about 100 ms, less than about 50 ms, less than about 25 ms, less than about 10 ms, less than about 5 ms, less than about 1 ms, or less than about 0.1 ms to occur. In another example, the intensity change can be gradual (e.g., taking at least about 0.1 ms, at least about 1 ms, at least about 5 ms, at least about 10 ms, at least about 25 ms, at least about 50 ms, at least about 100 ms, or at least about 200 ms to occur and / or occurs in a stepwise manner).
[0050] After step S126, the method 150 proceeds to Figure 1A However, the "No" branch from step S114 goes to Figure 1B In step S126. Figure 1B , method 150 may include applying one or more subsequent duty cycles of the alternating electric field of steps S126 , S110 , and S112 .
[0051] Figure 2 An exemplary system with four transducers (or "transducer arrays") 200A-D is depicted. The system can be used to treat a target area of a subject's body with an alternating electric field. In one example, the target area can be in the subject's brain, and the alternating electric field can be delivered to the subject's body via a pair of transducer arrays located on the subject's head. In another example, the target area can be in the subject's torso, and the alternating electric field can be delivered to the subject's body via a pair of transducer arrays located on one or both of the subject's chest, abdomen, or thighs. Other transducer array placements on the subject's body are also possible.
[0052] Each transducer 200A-D can include a substantially flat electrode element 202A-D located on a substrate 204A-D and electrically and physically connected (e.g., by conductive wiring 206A-D). The substrate 204A-D can include, for example, cloth, foam, flexible plastic, and / or conductive medical gel. Two transducers (e.g., 200A and 200D) can be a first pair of transducers configured to apply an alternating electric field to a target area of a subject's body. The other two transducers (e.g., 200B and 200C) can be a second pair of transducers that are similarly configured to apply an alternating electric field to a target area.
[0053] The transducers 200A-D can be coupled to a voltage generator 208 (i.e., an AC voltage generator), and the system also includes a controller 210 communicatively coupled to the AC voltage generator 208. The controller 210 can include a computer having one or more processors 212 and a memory 214 accessible by the one or more processors. The memory 214 can store instructions that, when executed by the one or more processors, control the voltage generator 208 to induce an alternating electric field between the transducers 200A-D pair according to one or more voltage waveforms and / or cause the computer to perform one or more methods disclosed herein. The controller 210 can monitor operations performed by the AC voltage generator 208 (e.g., via the processor 212). One or more sensors 216 can be coupled to the controller 210 for providing measurements or other information to the controller 210.
[0054] The voltage generator 208 can provide one or more voltages to different transducer pairs (e.g., 200A / D, 200B / C) for applying an alternating electric field to the subject's body. The controller 210 can instruct the voltage generator 208 to generate one or more voltages according to one or more waveforms. For example, referring to Figure 7 The described method may be implemented using the voltage generator 208 and the controller 210 .
[0055] In one example, the controller 210 can provide a signal to the first pair of transducers (200A, 200D) for controlling the first alternating electric field according to the first waveform, so that: the first alternating electric field starts with a first frequency; the first alternating electric field increases from zero intensity to a target intensity while maintaining the first frequency; after the first alternating electric field reaches the target intensity, it changes from the first frequency to a target frequency, which is lower than the first frequency. Similarly, the controller 210 can provide a signal to the second pair of transducers (200B, 200C) for controlling the second alternating electric field according to the same or similar waveform.
[0056] Figure 3 An exemplary device for use with embodiments herein is depicted. As an example, device 300 may be a computer implementing certain techniques disclosed herein. As an example, device 300 may be a controller device for applying an alternating electric field in embodiments herein. For example, device 300 may be used as Figure 2The device 300 may include one or more processors 302, a memory 304, and one or more output devices 306. The memory 304 may be accessible by the one or more processors 302, so that the one or more processors 302 may read information from and write information to the memory 304. The memory 304 may store instructions that, when executed by the one or more processors 302, implement one or more embodiments of the present invention. For example, the device 300 may include one or more processors and a memory accessible by the one or more processors, wherein the memory stores instructions that, when executed by the one or more processors, cause the device 300 to perform operations to implement one or more embodiments of the present invention.
[0057] In one example, based on input 308, one or more processors 302 can generate control signals to control the voltage generator to implement embodiments of the present invention. Input 308 can be user input, sensor input, or input from another computer in communication with device 300. Output device 306 can provide the operating status of the present invention, such as transducer selection, generated voltage, and other operating information. Output device 306 can provide visualization data.
[0058] Figure 4-6 Depicted are exemplary waveforms (400, 500, 600) that can be used to control and / or represent an alternating electric field according to the present invention. The waveforms (400, 500, 600) illustrate patterns of an alternating electric field during one or more duty cycles according to the method of FIG. 1. In one example, the waveforms (400, 500, 600) can represent the amplitude (402, 502, 602) of the intensity of the alternating electric field relative to time (404, 504, 604), or the amplitude (402, 502, 602) of a voltage applied to a pair of transducers relative to time (404, 504, 604).
[0059] like Figure 4 and Figure 5 As shown, the waveform (400, 500) may include an initial ramp-up period (406, 506) during which the amplitude (402, 502) of the waveform (400, 500) increases from zero (408, 508) to a target amplitude (410, 510) while the frequency of the waveform (400, 500) is at a first frequency. The waveform (400, 500) also includes a sustained intensity period (412, 512) during which the frequency of the waveform (400, 500) changes to a target frequency that is lower than the first frequency while the amplitude (402, 502) of the waveform (400, 500) remains at the target amplitude (410, 510).
[0060] like Figure 4As shown, the change of the frequency (e.g., alternating electric field) of waveform 400 from the first frequency to the target frequency can be performed once immediately (or almost immediately) during the application of the alternating electric field. In one example, the change of the frequency of waveform 400 from the first frequency to the target frequency can be performed in a period of less than 200 ms. In this way, waveform 400 can start at a higher frequency during the initial ramp-up period 406, and then immediately (or nearly immediately) switch to a lower optimal treatment frequency once a sufficiently high amplitude 402 is reached.
[0061] like Figure 5 As shown, the change in the frequency of waveform 500 (e.g., alternating electric field) from the first frequency to the target frequency can be performed gradually over a period of time during which the alternating electric field is applied (e.g., during sustained intensity period 512). In this way, waveform 500 can start at a higher frequency during an initial ramp-up period 506 and then gradually switch to a lower optimal treatment frequency once a sufficiently high amplitude 502 is reached. Figure 5 As shown, the frequency gradually changes from the first frequency to the target frequency during the sustained intensity period 512. In some embodiments, the frequency can gradually change from the first frequency to the target frequency during the initial ramp-up period 506 or during both the initial ramp-up period 506 and the sustained intensity period 512.
[0062] The alternating electric field according to the present invention may be applied using a voltage generated according to an AC voltage waveform (eg, 400, 500). Figure 4 and Figure 5 As shown, one or more frequency changes from the first frequency to the target frequency may be made, each corresponding to a zero crossing of the AC voltage waveform (e.g., 400, 500). A "zero crossing" may be any point in time (404, 504) where the amplitude (402, 502) is zero (408, 508). In one example, Figure 4 As shown, the change in frequency can be performed at a single time corresponding to the zero crossing of waveform 400. In another example, Figure 5 As shown, the change in frequency may be performed in a stepwise manner, with each shift occurring at a different zero crossing of waveform 500. Changing the frequency at one or more zero crossings provides a smooth transition of the electric field applied to the subject's body so that electric shock or electrosensitivity does not occur in the subject's body.
[0063] Figure 4 and Figure 5 Each represents a waveform (for example, as shown above Figure 2 A single duty cycle of the alternating electric field applied by the “first waveform”). Figure 6620A and 620B represent two duty cycles of an alternating electric field. Duty cycles 620A and 620B can be used for the same transducer or different transducers. As shown, the second duty cycle 620B follows a similar pattern of intensity (e.g., amplitude 602) and frequency as the first duty cycle 620A. The term "similar pattern" can refer to a general pattern of frequency change to a lower frequency after an initial ramp-up period (i.e., once the amplitude 602 reaches a target level). Thus, the frequency and amplitude between the first duty cycle 620A and the second duty cycle 620B do not have to be exactly the same, as long as they follow the same general pattern. In some embodiments, as Figure 6 As shown, the duty cycles 620A, 620B may be applied according to the same waveform 600 (ie, the first frequency, target frequency, and time when the frequency is changed are the same in both duty cycles).
[0064] Figure 7 An exemplary method 700 for treating a target area of a subject's body with an alternating electric field is shown. The method 700 may be used Figure 2 The method 700 may include, at step S702, generating a first voltage and providing it to a first pair of transducers, wherein the first voltage is generated according to a first waveform (e.g., an AC voltage waveform). The first waveform may be similar to Figures 4 to 6 That is, the first waveform may include an initial ramp-up period during which the amplitude increases from zero to a target amplitude when the frequency is at a first frequency, and thereafter, while the amplitude remains at the target amplitude, the frequency changes to a target frequency lower than the first frequency.
[0065] At step S704, method 700 may include generating and providing a second voltage to the second pair of transducers, the second voltage being generated according to the first waveform (e.g., an AC voltage waveform). At step S706, method 700 may include alternating between providing the first voltage to the first pair of transducers and providing the second voltage to the second pair of transducers. Step S706 may be repeated until a second time period has elapsed at step S708. After the second time period has elapsed, method 700 proceeds to step S710. Figure 7 The second time period (S708) may be the same as the second time period (S114) of FIG. 1 .
[0066] At step S710, method 700 may include generating and providing a third voltage to the first pair of transducers, the third voltage being generated according to a second waveform (e.g., an AC voltage waveform). The second waveform may include an initial ramp-up period during which the amplitude of the second waveform increases from zero to a target amplitude while the frequency of the second waveform is at a frequency lower than the first frequency. The frequency lower than the first frequency may be equal to the target frequency. The second waveform may include a sustained intensity period during which the frequency of the second waveform is at the target frequency while the amplitude remains at the target amplitude.
[0067] Figure 8 An exemplary method 800 of delivering an alternating electric field to a subject's body is shown. Method 800 includes, at step S802, applying a target alternating electric field to the subject's body to treat the subject's body. The target alternating electric field has a target frequency and a target intensity, and the target frequency and the target intensity have known efficacy in treating the subject's body. At step S804, method 800 includes receiving a response from the subject regarding electrosensitivity. The response from the subject may include feedback 806 from the subject, a measurement 808 of the subject (e.g., a sensor measurement), or both. At step S810, method 800 includes determining whether the response indicates that the subject's body experiences electrosensitivity from the target alternating electric field. If, at step S810, the response indicates that the subject's body does not experience electrosensitivity, method 800 proceeds to step S812: continuing to apply the target alternating electric field to the subject's body to treat the subject's body.
[0068] If, at step S810, the response indicates that the subject's body has experienced electrosensitivity, then method 800 proceeds to step S814: a first frequency of the alternating electric field is selected to reduce the electrosensitivity experienced by the subject's body. The first frequency is higher than the target frequency. At step S816, method 800 includes applying an alternating electric field to the subject's body, the alternating electric field having the first frequency while the intensity is ramped from zero to a target intensity and then changed to the target frequency when the target intensity is reached. Figure 8 The method 800 allows for tailoring the process of reducing or eliminating electrosensitivity for individual subjects, since not all subjects will experience electrosensitivity from the target alternating electric field.
[0069] Fig. 9An exemplary method 900 of delivering an alternating electric field to a subject's body when temperature increases is depicted. In method 900, the intensity and / or frequency of the alternating electric field can be changed as the temperature changes. In step S902, after applying an alternating electric field having a first frequency while increasing the intensity of the alternating electric field from zero to a target intensity in step S106, the temperature at which the alternating electric field is applied can be monitored. For example, the temperature of a transducer applying the alternating electric field, the temperature of a target area, and / or the temperature of the subject's skin at or near where the alternating electric field is applied can be monitored. The sensor that monitors the temperature can be part of the transducer or separate from the transducer.
[0070] At step S904, if the measured temperature is equal to or lower than the predetermined threshold, the process proceeds to step S902 and the cycle is repeated. The alternating electric field having the first frequency and the first intensity may continue to be applied to the subject's body. In one example, the predetermined threshold temperature of the transducer may be about 37°C to about 39°C, or about 38.5°C to about 39°C, or about 37°C to about 41.5°C. On the other hand, if the measured temperature is greater than the predetermined threshold, the process proceeds to step S906.
[0071] At step S906, a second intensity may be selected. In a non-limiting embodiment, the second intensity may be lower than the first intensity. For example, the second intensity may be at least 10% lower than the target intensity (e.g., at least about 20% lower, 30% lower, 40% lower, 50% lower, or 60% lower). For example, the second intensity may be at least 0.1 V / cm lower than the first intensity (e.g., at least about 0.2 V / cm, 0.3 V / cm, 0.4 V / cm, 0.5 V / cm, 0.6 V / cm, 0.7 V / cm, 0.8 V / cm, 0.9 V / cm, 1 V / cm, or 2 V / cm lower). For example, the second intensity may be from about 0.1 V / cm to about 20 V / cm, such as from about 0.5 V / cm to about 10 V / cm.
[0072] In step S908, a second frequency may be selected after selecting the second intensity. In one example, the second frequency may be lower than the first frequency and close to or at the target frequency to compensate for the reduced efficacy caused by the reduced intensity. For example, the second frequency may be at least 10% (e.g., at least about 20%, 30%, 40%, 50%, or 60%) lower than the first frequency without being lower than the target frequency. In one example, the second frequency may be at least about 10 kHz (e.g., at least about 20 kHz, 30 kHz, 50 kHz, 75 kHz, 100 kHz, 150 kHz, 200 kHz, or 300 kHz) lower than the target frequency without being lower than the target frequency. In one example, the second frequency may be based on a range of the first frequency.
[0073] In step S910, the application of an alternating electric field having a first frequency and a first intensity to the subject's body may be switched to the application of a second alternating electric field having a second frequency and a second intensity to the subject's body. In one example, the second alternating electric field may provide similar efficacy to the alternating electric field having the first frequency and the first intensity. In another example, the second alternating electric field may provide better efficacy than the alternating electric field having the first frequency and the first intensity. In a non-limiting embodiment, the alternating electric field may be generated by the same transducer or by different transducers. In a non-limiting embodiment, the first alternating electric field may be continuously switched to the second alternating electric field without shutting down the system / transducer or waiting time.
[0074] Experimental Results
[0075] Fig.10 Depicted is an exemplary cytotoxicity analysis showing the effect of field strength on the survival of various types of cancer. Cytotoxicity analysis was performed by counting the number of cells (percentage of control) after applying the disclosed frequency tumor treatment electric field to cell lines from various types of cancer for 72 hours: glioblastoma (U373, U87-MG, and A172; 200kHz), lung (NCI-H520 and A549; 150kHz), mesothelioma (MSTO-211 and H2052; 150kHz), stomach (KATO III and AGS; 150kHz), ovary (OVCAR-3, Caov-3 and A2780; 200kHz), and cervix (HeLa and Ca-Ski; 150kHz).
[0076] FIG. 11A to FIG. 11C Depicted is the experimental stimulation of the rat sciatic nerve fascicle with an alternating electric field. Fig.11A Five graphs showing neural responses after treatment with increasing voltages (4,000 mV, 6,000 mV, 8,000 mV, 10,000 mV, and 12,500 mV) are depicted. As the voltage increases, the neural response increases. Fig. 11B Stimulus amplitude in mVp-p is plotted against response amplitude in mV (blue circles, "A") and response width in msec (red circles, "B"). Response width is a proxy for velocity along a nerve fascicle. As response amplitude increases, more neurons in the fascicle are activated.
[0077] Fig. 11C Graphs from representative experiments are depicted where amplitude, frequency, and both amplitude and frequency were dimmed for 100 ms. Human testing was performed on an electric field generator with a 100ms dimming cycle, where the frequency was reduced from 300Hz to 100Hz. When the amplitude was increased in 1 millisecond steps, the threshold for electrosensitivity was 0.8A. When both the amplitude and frequency were dimmed, the threshold for electrosensitivity was approximately 1.4-1.5A.
[0078] The AM graph shows the neural response to stimulation in which the amplitude was increased from 500 mV to 12.5 V in 100 microseconds. The FM graph shows a similar response to stimulation in which the frequency was reduced from 400 Hz to 200 Hz in 100 microseconds. The AM+FM graph shows no response to stimulation in which the amplitude was increased simultaneously and the frequency was reduced simultaneously. The bottom three graphs depict a repetition of the experiment depicted in the top three graphs, which generated fairly similar results. The right graph depicts the measured response for each treatment; increasing both the amplitude and the frequency did not produce an action potential.
[0079] The present invention includes the following additional illustrative embodiments ("embodiments").
[0080] Embodiment 1: A method for treating a target area of a subject's body with an alternating electric field, the method comprising: applying an alternating electric field to the target area of the subject's body at a first frequency while increasing the intensity of the alternating electric field from zero to a target intensity; and changing the frequency of the alternating electric field from the first frequency to a target frequency while maintaining the alternating electric field at the target intensity, wherein the target frequency and the target intensity have known efficacy for treating the target area of the subject's body with the alternating electric field; and wherein the first frequency is greater than the target frequency.
[0081] Embodiment 2: The method according to embodiment 1, wherein changing the frequency of the alternating electric field is performed once and instantly during the application of the alternating electric field.
[0082] Embodiment 3: The method of embodiment 2, wherein: applying the alternating electric field using a voltage generated according to an AC voltage waveform, and changing the frequency of the alternating electric field is performed at a time corresponding to a zero crossing of the AC voltage waveform.
[0083] Embodiment 4: The method according to embodiment 1, wherein changing the frequency of the alternating electric field is performed within less than 200 ms.
[0084] Embodiment 5: The method of embodiment 4, wherein: applying the alternating electric field using a voltage generated according to an AC voltage waveform, and changing the frequency of the alternating electric field is performed at a time corresponding to a zero crossing of the AC voltage waveform.
[0085] Embodiment 6: The method according to embodiment 1, wherein changing the frequency of the alternating electric field is performed gradually over a period of time during which the alternating electric field is applied.
[0086] Embodiment 7: The method of embodiment 6, wherein: the alternating electric field is applied using a voltage generated according to an AC voltage waveform, and changing the frequency of the alternating electric field is performed in a stepwise manner, wherein each shift occurs at a different zero crossing of the AC voltage waveform.
[0087] Embodiment 8: According to the method of claim 1, the method further comprises: after the first time period, stopping applying the alternating electric field to complete the first duty cycle of the alternating electric field; applying one or more subsequent duty cycles of the alternating electric field, each subsequent duty cycle following the same intensity and frequency pattern as the first duty cycle.
[0088] Embodiment 9: The method of embodiment 8, wherein the alternating electric field is applied using a voltage generated according to an AC voltage waveform, wherein each duty cycle of the alternating electric field is applied according to the same AC voltage waveform.
[0089] Embodiment 10: According to the method of Embodiment 8, the method further includes: after a second time period, switching from applying an alternating electric field to a target area of the subject's body to applying a second alternating electric field to the target area of the subject's body at a second frequency, wherein the second frequency is lower than the first frequency and is close to or at the target frequency in each duty cycle.
[0090] Embodiment 11: The method according to embodiment 10, wherein the second time period is about 12 hours to about 4 weeks.
[0091] Embodiment 12: The method according to embodiment 8, wherein the first time period is less than three seconds.
[0092] Embodiment 13: The method according to embodiment 1, wherein the target frequency is about 50 kHz to about 1 MHz.
[0093] Embodiment 14: The method according to embodiment 1, wherein the target frequency is about 50 kHz to about 500 kHz.
[0094] Embodiment 15: The method of embodiment 1, wherein the first frequency is at least about 10% higher than the target frequency.
[0095] Embodiment 16: The method of embodiment 1, wherein the first frequency is at least about 10 kHz higher than the target frequency.
[0096] Embodiment 17: The method according to embodiment 1, wherein the target intensity is about 0.1 V / cm to about 10.0 V / cm.
[0097] Embodiment 18: The method of Embodiment 1, wherein the alternating electric field is configured to reduce electrosensitivity of the subject compared to when the alternating electric field is applied at the target frequency throughout its duty cycle.
[0098] Example 19: The method of Example 1, wherein the target area is glioblastoma (GBM), wherein the target frequency is about 100 kHz to about 300 kHz.
[0099] Embodiment 20: The method according to embodiment 1, wherein the target area is endothelial or epithelial tight junctions, wherein the target frequency is about 50 kHz to about 190 kHz.
[0100] Embodiment 21: The method of embodiment 1, wherein the alternating electric field is delivered to the subject's body to alter cancer cell membrane permeability, wherein the target frequency is about 100 kHz to about 500 kHz.
[0101] Embodiment 22: The method of Embodiment 1, wherein the alternating electric field is delivered to the subject's body via a pair of transducer arrays located on the head of the subject's body, wherein the target area is in the subject's brain.
[0102] Example 23: A method according to Example 1, wherein the alternating electric field is delivered to the subject's body via a pair of transducer arrays positioned on at least one of one or both of the chest, abdomen, or thighs of the subject's body, wherein the target area is in the subject's torso.
[0103] Embodiment 24: A device for treating a target area of a subject's body with an alternating electric field, the device comprising: a first pair of transducers configured to apply a first alternating electric field to the target area of the subject's body; a voltage generator coupled to the first pair of transducers and capable of providing a first voltage to the first pair of transducers for applying the first alternating electric field; and a controller coupled to the voltage generator, the controller comprising one or more processors and a memory accessible by the one or more processors, the memory storing instructions that, when executed by the one or more processors, cause the controller to instruct the voltage generator to generate the first voltage according to a first waveform, the first waveform having: an initial ramp-up period, during which, when the frequency of the first waveform is at a first frequency, the amplitude of the first waveform increases from zero to a target amplitude; and a sustained intensity period, during which the frequency of the first waveform is changed to a target frequency lower than the first frequency, while the amplitude of the first waveform is maintained at the target amplitude.
[0104] Embodiment 25: The apparatus of embodiment 24, wherein the frequency of the first waveform is instantly changed from the first frequency to the target frequency.
[0105] Embodiment 26: The apparatus of embodiment 25, wherein the frequency of the first waveform changes at a zero crossing of the first waveform.
[0106] Embodiment 27: The device according to embodiment 24, wherein the frequency of the first waveform changes from the first frequency to the target frequency in less than 200 ms.
[0107] Embodiment 28: The apparatus of embodiment 27, wherein the frequency of the first waveform changes at zero crossings of the first waveform.
[0108] Embodiment 29: The device according to embodiment 24, wherein the frequency of the first waveform gradually changes from the first frequency to the target frequency.
[0109] Embodiment 30: The apparatus of embodiment 29, wherein the frequency of the first waveform is changed in a stepwise manner, wherein each shift occurs at a different zero crossing of the first waveform.
[0110] Embodiment 31: A device according to embodiment 24, wherein the voltage generator is coupled to the first pair of transducers and is capable of providing a third voltage to the first pair of transducers so as to apply a third alternating electric field to a target area of the subject's body, and the instructions, when executed by the one or more processors, cause the controller to instruct the voltage generator to generate the third voltage according to a second waveform, the second waveform having: an initial ramp-up period, during which the amplitude of the second waveform increases from zero to the target amplitude while the frequency of the second waveform is at a frequency lower than the first frequency; and a sustained intensity period, during which the frequency of the second waveform is at the target frequency while the amplitude of the second waveform is maintained at the target amplitude.
[0111] Embodiment 32: The apparatus of Embodiment 31, wherein the second waveform is at the target frequency during the initial ramp-up period.
[0112] Embodiment 33: The device according to embodiment 24 further includes: a second pair of transducers, which are configured to apply a second alternating electric field to a target area of the subject's body, wherein the voltage generator is coupled to the second pair of transducers and is capable of providing a second voltage to the second pair of transducers to apply the second alternating electric field, and the instructions, when executed by the one or more processors, cause the controller to instruct the voltage generator to generate the second voltage according to the first waveform.
[0113] Embodiment 34: The apparatus of Embodiment 33, wherein the instructions, when executed by the one or more processors, cause the controller to instruct the voltage generator to alternately switch between providing the first voltage to the first pair of transducers and providing the second voltage to the second pair of transducers at regular intervals.
[0114] Embodiment 35: A method of delivering an alternating electric field to a subject's body, the method comprising: applying a target alternating electric field to the subject's body to treat the subject's body, the target alternating electric field having a target frequency and a target intensity, the target frequency and the target intensity having known efficacy for treating the subject's body; receiving a response from the subject regarding electrosensitivity, wherein the response from the subject comprises at least one of feedback from the subject or a measurement of the subject; if the response indicates that the subject's body experiences electrosensitivity from the target alternating electric field, selecting a first frequency for the alternating electric field to reduce the electrosensitivity experienced by the subject's body from the target alternating electric field, the first frequency being higher than the target frequency; and applying an alternating electric field to the subject's body, the alternating electric field having the first frequency while ramping up the intensity from zero to the target intensity and then changing to the target frequency when the target intensity is reached.
[0115] Embodiment 36: A device for treating a target area of a subject's body with an alternating electric field, the device comprising: a pair of transducers, the pair of transducers configured to apply a first alternating electric field to the target area of the subject's body; and a controller implemented with at least one processor, the controller for providing a signal for controlling the first alternating electric field to the pair of transducers so that: the first alternating electric field starts with a first frequency; the first alternating electric field increases from zero intensity to a target intensity while maintaining the first frequency; and after the first alternating electric field reaches the target intensity, it changes from the first frequency to a target frequency, which is lower than the first frequency.
[0116] Example 37: A method for treating a target area of a subject's body with an alternating electric field, the method comprising: applying an alternating electric field to the target area of the subject's body at a first frequency while increasing the current of the alternating electric field from zero to a target current; and changing the frequency of the alternating electric field from the first frequency to a target frequency while maintaining the alternating electric field at the target current, wherein the target frequency and the target current have known efficacy for treating the target area of the subject's body with the alternating electric field; and wherein the first frequency is greater than the target frequency.
[0117] Illustrative Example 38. A method of delivering an alternating electric field to a subject's body, the method comprising: applying a target alternating electric field to the subject's body to treat the subject's body, the target alternating electric field having a target frequency and a target intensity, the target frequency and the target intensity having known efficacy for treating the subject's body; receiving feedback from applying the target alternating electric field regarding electrosensitivity experienced by the subject's body; if the subject's body experiences electrosensitivity from the target alternating electric field of the target frequency and target intensity, selecting at least one of a first frequency or a first intensity of the alternating electric field to reduce electrosensitivity experienced by the subject's body from the target alternating electric field, the first frequency being higher than the target frequency and the first intensity being lower than the target intensity; and applying a first alternating electric field to the subject's body to treat the subject's body, the first alternating electric field having at least one of the first frequency or the first intensity.
[0118] Illustrative Embodiment 39. The method of Illustrative Embodiment 38, wherein the first frequency is at least about 10% higher than the target frequency, and wherein the first intensity is at least about 10% lower than the target intensity.
[0119] Illustrative embodiment 40. The method of illustrative embodiment 39, further comprising: after a time interval, ceasing to apply the first alternating electric field to the subject's body; and applying a second alternating electric field to the subject's body at least one of a second frequency close to or at the target frequency or a second intensity close to or at the target intensity.
[0120] Illustrative Embodiment 41. A method of delivering an alternating electric field to a subject's body, the method comprising: applying the alternating electric field to a target area of the subject's body, wherein the alternating electric field has a first frequency and a first intensity, wherein for the target frequency and target intensity of the alternating electric field, the subject experiences electrosensitivity, wherein the first intensity is the target intensity, and wherein the first frequency is greater than the target frequency.
[0121] Illustrative Embodiment 42. The method of Illustrative Embodiment 41, wherein the alternating electric field is configured to reduce electrosensitivity of the subject compared to when the alternating electric field is applied at a target frequency and a target intensity.
[0122] Illustrative Embodiment 43. The method of Illustrative Embodiment 41, further comprising determining a first strength of the alternating electric field before applying the alternating electric field; and after determining the first strength, identifying the first frequency of the alternating electric field based on a response from the subject regarding electrosusceptibility experienced by the subject, wherein the first frequency is a frequency of the alternating electric field that reduces electrosusceptibility in the subject at the first strength.
[0123] Illustrative Embodiment 44. The method of Illustrative Embodiment 43, wherein identifying the first frequency of the alternating electric field comprises: gradually reducing the frequency level of the alternating electric field from an initial frequency until a response from the subject indicates that the subject is experiencing electrosensitivity.
[0124] Illustrative Embodiment 45. The method of Illustrative Embodiment 43, wherein the response from the subject comprises at least one of feedback from the subject or a measurement of the subject.
[0125] Illustrative Embodiment 46. The method according to Illustrative Embodiment 41, wherein the target frequency is about 100 kHz to about 400 kHz, and the target intensity is about 0.5 V / cm to about 10.0 V / cm.
[0126] Illustrative embodiment 47. The method of illustrative embodiment 41, further comprising, when the temperature at which the alternating electric field is applied reaches a threshold temperature, determining a second strength of the alternating electric field, wherein the second strength is lower than the first strength; identifying a second frequency of the alternating electric field, wherein the second frequency is lower than the first frequency; and switching from applying the alternating electric field to applying another alternating electric field having a second strength and a second frequency.
[0127] Illustrative Embodiment 48. The method of Illustrative Embodiment 41, further comprising, after a time interval, switching from applying the alternating electric field to the target area of the subject's body to applying a second alternating electric field to the target area of the subject's body at a lower frequency that is closer to or at the target frequency.
[0128] Illustrative Embodiment 49. The method according to Illustrative Embodiment 48, wherein the interval between applying the alternating electric field having the first frequency and the second alternating electric field having the lower frequency is about 12 hours to about 4 weeks (eg, about 12 hours to about 2 weeks).
[0129] Illustrative embodiment 50. The method of illustrative embodiment 41, wherein the first frequency is at least about 10% higher than the target frequency.
[0130] Illustrative Embodiment 51. The method of Illustrative Embodiment 41, wherein the first frequency is at least about 10 kHz higher than the target frequency.
[0131] Illustrative Embodiment 52. The method according to Illustrative Embodiment 41, wherein the target area is a glioblastoma (GBM), wherein the target frequency is about 50 kHz to about 350 kHz, and the target intensity is about 1 V / cm to about 5 V / cm.
[0132] Illustrative Embodiment 53. The method according to Illustrative Embodiment 41, wherein the target region is the blood-brain barrier (BBB), wherein the target frequency is about 50 kHz to about 190 kHz, and the target intensity is about 1 V / cm to about 5 V / cm.
[0133] Illustrative Embodiment 54. The method according to Illustrative Embodiment 41, wherein the alternating electric field is delivered to the subject's body to alter cell membrane permeability, wherein the target frequency is about 50 kHz to about 550 kHz, and the target intensity is about 0.5 V / cm to about 20 V / cm.
[0134] Illustrative Embodiment 55. An apparatus for treating a target area of a subject's body with an alternating electric field, the apparatus comprising: a transducer configured to apply the alternating electric field to the target area of the subject's body; and a controller implemented with at least one processor for providing a signal for the alternating electric field to the transducer, wherein the alternating electric field has a first frequency and a target intensity, wherein the subject experiences electrosensitivity for a frequency and intensity with known efficacy for treating the target area of the subject's body with the alternating electric field, wherein the first intensity is an intensity with the known efficacy, and wherein the first frequency is greater than the frequency with the known efficacy.
[0135] Illustrative embodiment 56. The device according to illustrative embodiment 55, wherein the controller includes one or more processors; and a memory storing processor-executable instructions that, when executed by the one or more processors, cause the controller to determine a first strength of the alternating electric field before applying the alternating electric field; and after determining the first strength, identify the first frequency of the alternating electric field based on a response from the subject regarding electrosusceptibility experienced by the subject, wherein the first frequency is a frequency of the alternating electric field that reduces electrosusceptibility of the subject at the first strength.
[0136] Illustrative Embodiment 57. The apparatus of Illustrative Embodiment 56, wherein the response from the subject comprises at least one of feedback from the subject or a measurement of the subject.
[0137] Illustrative embodiment 58. The device of illustrative embodiment 56, wherein the memory stores processor-executable instructions that, when executed by the one or more processors, further cause the device to gradually reduce the frequency level of the alternating electric field from an initial frequency until feedback from the subject indicates that the subject is experiencing electrosensitivity.
[0138] Illustrative embodiment 59. The device of illustrative embodiment 56, wherein the memory stores processor-executable instructions that, when executed by the one or more processors, further cause the device to gradually reduce the frequency level of the alternating electric field from an initial frequency until measurements of neural stimulation of the subject indicate that the subject experiences electrosensitivity.
[0139] Illustrative embodiment 60. The device according to illustrative embodiment 55, wherein the controller includes one or more processors; and a memory storing processor-executable instructions, which when executed by the one or more processors cause the controller to determine a second strength of the alternating electric field when the temperature at which the alternating electric field is applied reaches a threshold temperature, the second strength being lower than the first strength; identify a second frequency of the alternating electric field, wherein the second frequency is lower than the first frequency; and apply the alternating electric field having the second strength and the second frequency.
[0140] Illustrative Embodiment 61. The apparatus of Illustrative Embodiment 55, wherein the alternating electric field is capable of applying a tumor treating electric field, opening the subject's blood-brain barrier, disrupting the subject's cell membrane, or changing the permeability of the subject's cell membrane.
[0141] Illustrative Embodiment 62. An apparatus for calibrating delivery of an alternating electric field to a subject's body, the apparatus comprising: one or more processors; and a memory storing processor-executable instructions that, when executed by the one or more processors, cause the apparatus to determine a target frequency and a target intensity for applying the alternating electric field to treat a target area of the subject's body, the target frequency and the target intensity having known efficacy for treating the subject's body; and select a first frequency for applying the alternating electric field to treat the target area of the subject's body, the first frequency being selected to reduce electrosensitivity experienced in the subject's body at the target intensity, wherein the first frequency is higher than the target frequency.
[0142] Illustrative Embodiment 63. The device of Illustrative Embodiment 62, wherein the target frequency and the target intensity have known efficacy for treating a tumor, opening the subject's blood-brain barrier, disrupting a cell membrane of the subject, or changing the permeability of a cell membrane of the subject.
[0143] Illustrative Example 64. A method of delivering an alternating electric field to a subject's body, the method comprising: applying a target alternating electric field to the subject's body to treat the subject's body, the target alternating electric field having a target frequency and a target intensity, the target frequency and the target intensity having known efficacy for treating the subject's body; receiving a response from the subject regarding electrosensitivity, wherein the response from the subject comprises at least one of feedback from the subject or a measurement by the subject; if the response indicates that the subject's body experiences electrosensitivity from the target alternating electric field at the target frequency and the target intensity, selecting a first frequency for the alternating electric field to reduce electrosensitivity experienced by the subject's body from the target alternating electric field, the first frequency being higher than the target frequency; and applying a first alternating electric field to the subject's body to treat the subject's body, the first alternating electric field having the first frequency and the target intensity.
[0144] Illustrative Embodiment 65. The method of Illustrative Embodiment 64, wherein the first frequency is at least about 10% higher than the target frequency.
[0145] Illustrative Embodiment 66. The method of Illustrative Embodiment 64, further comprising, after a time interval, switching from applying the first alternating electric field to the subject's body to applying a second alternating electric field to the subject's body at a second frequency close to or at the target frequency.
[0146] Illustrative embodiment 67: A method for treating a target area of a subject's body with an alternating electric field, the method comprising: applying the alternating electric field to the target area of the subject's body at a certain frequency and intensity, wherein the frequency is a first frequency, wherein the intensity is a first intensity; and increasing the intensity from the first intensity to a target intensity while decreasing the frequency from the first frequency to a target frequency, wherein the target frequency and the target intensity have a known efficacy for treating the target area of the subject's body with the alternating electric field; wherein the first frequency is greater than the target frequency; and wherein the first intensity is less than the target intensity.
[0147] Illustrative Embodiment 68: The method of Embodiment 67, wherein during application of the alternating electric field, the frequency is immediately reduced from the first frequency to the target frequency.
[0148] Illustrative Embodiment 69: The method of Embodiment 67, wherein increasing the strength of the alternating electric field while decreasing the first frequency is performed within a period of less than 200 ms.
[0149] Illustrative Embodiment 70: The method of Embodiment 67, wherein, during the application of the alternating electric field, the intensity of the alternating electric field is gradually increased while the first frequency is decreased over a period of time.
[0150] Illustrative embodiment 71: According to the method of claim 67, the method further includes: after a first time period, stopping applying the alternating electric field to complete a first duty cycle of the alternating electric field; applying one or more subsequent duty cycles of the alternating electric field, each subsequent duty cycle following the same intensity and frequency pattern as the first duty cycle.
[0151] Illustrative Embodiment 72: The method of Embodiment 71, wherein the alternating electric field is applied using a voltage generated from an AC voltage waveform, wherein each duty cycle of the alternating electric field is applied from the same AC voltage waveform.
[0152] Illustrative embodiment 73: According to the method of embodiment 71, the method also includes: after the second time period, switching from applying the alternating electric field to the target area of the subject's body to applying a second alternating electric field to the target area of the subject's body at a second frequency, wherein the second frequency is lower than the first frequency and is close to or at the target frequency in each duty cycle.
[0153] Illustrative Embodiment 74: The method of Embodiment 73, wherein the second period of time is from about 12 hours to about 4 weeks.
[0154] Illustrative Embodiment 75: The method of Embodiment 71, wherein the first time period is less than three seconds.
[0155] Illustrative Embodiment 76: The method of Embodiment 67, wherein the target frequency is about 50 kHz to about 1 MHz.
[0156] Illustrative Embodiment 77: The method of Embodiment 67, wherein the target frequency is about 50 kHz to about 500 kHz.
[0157] Illustrative Embodiment 78: The method of Embodiment 67, wherein the first frequency is at least about 10% higher than the target frequency.
[0158] Illustrative Embodiment 79: The method of Embodiment 67, wherein the first frequency is at least about 10 kHz higher than the target frequency.
[0159] Illustrative Embodiment 80: The method of Embodiment 67, wherein the target intensity is about 0.1 V / cm to about 10.0 V / cm.
[0160] Illustrative Embodiment 81: The method of Embodiment 67, wherein the alternating electric field is configured to reduce electrosensitivity of the subject compared to when the alternating electric field is applied at the target frequency throughout its duty cycle.
[0161] Illustrative Embodiment 82: The method of Embodiment 67, wherein the target area is glioblastoma (GBM), wherein the target frequency is about 100 kHz to about 300 kHz.
[0162] Illustrative Embodiment 83: The method of Embodiment 67, wherein the target area is endothelial or epithelial tight junctions, wherein the target frequency is about 50 kHz to about 190 kHz.
[0163] Illustrative Embodiment 84: The method according to Embodiment 67, wherein the alternating electric field is delivered to the subject's body to alter cancer cell membrane permeability, wherein the target frequency is about 100 kHz to about 500 kHz.
[0164] Illustrative Embodiment 85: The method of Embodiment 67, wherein the alternating electric field is delivered to the subject's body via a pair of transducer arrays located on the head of the subject's body, wherein the target area is in the subject's brain.
[0165] Illustrative Embodiment 86: The method of Embodiment 67, wherein the alternating electric field is delivered to the subject's body via a pair of transducer arrays positioned on at least one of one or both of the chest, abdomen, or thighs of the subject's body, wherein the target area is in the subject's torso.
[0166] Illustrative embodiment 87: A device for treating a target area of a subject's body with an alternating electric field, the device comprising: a first pair of transducers configured to apply a first alternating electric field to the target area of the subject's body; a voltage generator coupled to the first pair of transducers and capable of providing a first voltage to the first pair of transducers for applying the first alternating electric field; and a controller coupled to the voltage generator, the controller comprising one or more processors and a memory accessible by the one or more processors, the memory storing instructions that, when executed by the one or more processors, cause the controller to perform the following operations: apply the alternating electric field to the target area of the subject's body at a first frequency while increasing the intensity of the alternating electric field from zero to a target intensity; and change the frequency of the alternating electric field from the first frequency to a target frequency while maintaining the alternating electric field at the target intensity, wherein the target frequency and the target intensity have known efficacy for treating the target area of the subject's body with the alternating electric field; and wherein the first frequency is greater than the target frequency.
[0167] Illustrative embodiment 88: A device for treating a target area of a subject's body with an alternating electric field, the device comprising: a first pair of transducers configured to apply a first alternating electric field to the target area of the subject's body; a voltage generator coupled to the first pair of transducers and capable of providing a first voltage to the first pair of transducers for applying the first alternating electric field; and a controller coupled to the voltage generator, the controller comprising one or more processors and a memory accessible by the one or more processors, the memory storing instructions that, when executed by the one or more processors, cause the controller to perform the following operations: apply the alternating electric field to the target area of the subject's body at a certain frequency and intensity, wherein the frequency is a first frequency, wherein the intensity is a first intensity; and increase the intensity from the first intensity to a target intensity while decreasing the frequency from the first frequency to a target frequency, wherein the target frequency and the target intensity have a known efficacy for treating the target area of the subject's body with the alternating electric field, wherein the first frequency is greater than the target frequency, and wherein the first intensity is less than the target intensity.
[0168] Embodiments shown under any heading or any section of the invention may be combined with embodiments shown under the same or any other heading or other section of the invention unless otherwise indicated herein or clearly contradicted by context.
[0169] Numerous modifications, changes and variations may be made to the embodiments without departing from the scope of the invention as defined by the claims.The present invention is not limited to the embodiments described, but has the full scope defined by the language of the appended claims and their equivalents.
Claims
1. A device for treating a target area of a subject's body with an alternating electric field, the device include: a first pair of transducers configured to apply a first alternating electric field to a target region of the subject's body; a voltage generator coupled to the first pair of transducers and capable of providing a first voltage to the first pair of transducers for applying the first alternating electric field; as well as A controller coupled to the voltage generator, the controller comprising one or more processors and a memory accessible by the one or more processors, the memory storing instructions that, when executed by the one or more processors, cause the controller to perform operations including: applying the alternating electric field to the target area of the subject's body at a first frequency while increasing the intensity of the alternating electric field from zero to a target intensity; and changing the frequency of the alternating electric field from the first frequency to a target frequency while maintaining the alternating electric field at the target intensity, wherein the target frequency and the target intensity have known efficacy for treating the target area of the subject's body with the alternating electric field; and Wherein, the first frequency is greater than the target frequency.
2. The device according to claim 1, in: applying the alternating electric field using a voltage generated from an AC voltage waveform, and Changing the frequency of the alternating electric field is performed at moments corresponding to zero crossings of the AC voltage waveform.
3. The device according to claim 1, in, The frequency of the alternating electric field is gradually varied over a period of time during which the alternating electric field is applied.
4. The device according to claim 3, in: applying the alternating electric field using a voltage generated from an AC voltage waveform, and The frequency of the alternating electric field is varied in a stepwise manner, wherein each shift occurs at a different zero crossing of the AC voltage waveform.
5. The device according to claim 1, further comprising: include: After the first time period, stopping applying the alternating electric field to complete a first duty cycle of the alternating electric field; One or more subsequent duty cycles of the alternating electric field are applied, each subsequent duty cycle following a similar intensity and frequency pattern as the first duty cycle.
6. A device for treating a target area of a subject's body with an alternating electric field, the device include: a first pair of transducers configured to apply a first alternating electric field to a target region of the subject's body; a voltage generator coupled to the first pair of transducers and capable of providing a first voltage to the first pair of transducers for applying the first alternating electric field; as well as a controller coupled to the voltage generator, the controller comprising one or more processors and a memory accessible by the one or more processors, the memory storing instructions that, when executed by the one or more processors, cause the controller to instruct the voltage generator to generate the first voltage according to a first waveform, the first waveform having: an initial ramp-up period during which the amplitude of the first waveform increases from zero to a target amplitude when the frequency of the first waveform is at a first frequency; as well as A sustained intensity period during which the frequency of the first waveform is changed to a target frequency that is lower than the first frequency, while the amplitude of the first waveform is maintained at the target amplitude.
7. The device according to claim 6, in, The frequency of the first waveform is instantly changed from the first frequency to the target frequency.
8. The device according to claim 7, in, The frequency of the first waveform changes at zero crossings of the first waveform.
9. The device according to claim 6, in, The frequency of the first waveform changes from the first frequency to the target frequency in less than 200 ms.
10. The device according to claim 9, in, The frequency of the first waveform changes at zero crossings of the first waveform.
11. The device according to claim 6, in, The frequency of the first waveform gradually changes from the first frequency to the target frequency.
12. The device according to claim 11, in, The frequency of the first waveform is changed in a stepwise manner, wherein each shift occurs at a different zero crossing of the first waveform.
13. The device according to claim 6, in, The target frequency is from about 50 kHz to about 500 kHz, and wherein the target intensity is from about 0.1 V / cm to about 10.0 V / cm.
14. The device according to claim 6, in, The first frequency is at least about 10 kHz higher than the target frequency.
15. A device for treating a target area of a subject's body with an alternating electric field, the device include: a first pair of transducers configured to apply a first alternating electric field to a target region of the subject's body; a voltage generator coupled to the first pair of transducers and capable of providing a first voltage to the first pair of transducers for applying the first alternating electric field; as well as a controller coupled to the voltage generator, the controller comprising one or more processors and a memory accessible by the one or more processors, the memory storing instructions that, when executed by the one or more processors, cause the controller to perform operations including: applying the alternating electric field to the target area of the subject's body at a frequency and an intensity, wherein the frequency is a first frequency, and wherein the intensity is a first intensity; and increasing the intensity from the first intensity to a target intensity while decreasing the frequency from the first frequency to a target frequency, wherein the target frequency and the target intensity have known efficacy for treating the target area of the subject's body with the alternating electric field, wherein the first frequency is greater than the target frequency, and The first intensity is less than the target intensity.
Citation Information
Cited By
Control method and control device for tumor treating fields system, tumor treating fields system, computer-readable storage medium, and computer program product
WO2026222785A1
